Real-time enrollment status for this melanoma stage iii clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 12:09 AM UTC
| NCT Number | NCT06284590 |
| Recruiting Status | Recruiting |
| Condition | Melanoma Stage III |
| Phase | Clinical Trial |
| Target Enrollment | 162 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Philogen S.p.A. |
| Last Updated on CT.gov | October 26, 2024 (Oct 26, 2024) |
As of July 14, 2026: Clinical trial NCT06284590 is currently recruiting participants. This clinical trial study for melanoma stage iii is actively seeking new participants at 1 location across the United States. The study is sponsored by Philogen S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06284590 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06284590 was last updated Oct 26, 2024 (October 26, 2024). HelloStudys verifies this status automatically.